These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26405648)

  • 1. Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis.
    Grossmann ME; Yang DQ; Guo Z; Potter DA; Cleary MP
    Curr Pharmacol Rep; 2015 Apr; 1(5):312-323. PubMed ID: 26405648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena.
    Martin-Castillo B; Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
    Cell Cycle; 2010 Mar; 9(6):1057-64. PubMed ID: 20305377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidimensional mechanisms of metformin in cancer treatment.
    Singh-Makkar S; Pandav K; Hathaway D; Paul T; Youssef P
    Tumori; 2022 Apr; 108(2):111-118. PubMed ID: 34139918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin: Focus on Melanoma.
    Jaune E; Rocchi S
    Front Endocrinol (Lausanne); 2018; 9():472. PubMed ID: 30186236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of metformin in breast cancer: involvement of the immune system?
    Schott S; Bierhaus A; Schuetz F; Beckhove P; Schneeweiss A; Sohn C; Domschke C
    Cancer Immunol Immunother; 2011 Sep; 60(9):1221-5. PubMed ID: 21681370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
    Ikhlas S; Ahmad M
    Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin: Possible Use of a Diabetes Drug in Treatment of Cancer.
    Vacheron A; Wynn A; Zuber J; Solomon SS
    Clin Res Diabetes Endocrinol; 2018; 1(1):. PubMed ID: 33385166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer.
    Athreya AP; Kalari KR; Cairns J; Gaglio AJ; Wills QF; Niu N; Weinshilboum R; Iyer RK; Wang L
    Oncotarget; 2017 Apr; 8(16):27199-27215. PubMed ID: 28423712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposal for the locus of metformin's clinical action: potentiation of the activation of pyruvate kinase by fructose-1,6-diphosphate.
    McCarty MF
    Med Hypotheses; 1999 Feb; 52(2):89-93. PubMed ID: 10340287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Decreases 2-HG Production through the MYC-PHGDH Pathway in Suppressing Breast Cancer Cell Proliferation.
    Oh S; Cho Y; Chang M; Park S; Kwon H
    Metabolites; 2021 Jul; 11(8):. PubMed ID: 34436421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.
    Zhang J; Li G; Chen Y; Fang L; Guan C; Bai F; Ma M; Lyu J; Meng QH
    J Cancer; 2017; 8(10):1849-1864. PubMed ID: 28819383
    [No Abstract]   [Full Text] [Related]  

  • 15. To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke Rodents.
    Arbeláez-Quintero I; Palacios M
    Stroke Res Treat; 2017; 2017():9756429. PubMed ID: 28634570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
    Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
    Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: taking away the candy for cancer?
    Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
    Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy.
    Zhang Y; Storr SJ; Johnson K; Green AR; Rakha EA; Ellis IO; Morgan DA; Martin SG
    Oncotarget; 2014 Dec; 5(24):12936-49. PubMed ID: 25427448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AMP-activated protein kinase in mechanism of metformin action.
    Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
    J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.